comparemela.com

Latest Breaking News On - Presentation session - Page 4 : comparemela.com

Onera Health: Onera Launches Medical Advisory Board to Support Company Growth

Onera Health has announced the formation of a Medical Advisory Board ahead of SLEEP 2023, the Associated Professional Sleep Societies, LLC (APSS) annual meeting, where the company exhibits and presents

United statesHartmut schneider baltimoreHartmut schneiderSteven coughlinLudger grote gothenburgSwea ann hagenhoffOnera coIndiana convention centerMonera healthMedical advisory boardAssociated professional sleep societiesLudger groteDavid whiteRuben de franciscoChief medical officerPresentation session

Onera Establishes Medical Advisory Board

Onera Health, developer of a patch-based home sleep test, established a medical advisory board to support company growth.

United statesDavid whiteLudger groteSteven coughlinHartmut schneiderMonera healthJohns hopkins school of medicineSahlgrenska university hospital in gothenburgIndiana convention centerDisorders centerSleep disorders centerSahlgrenska university hospitalJohns hopkins schoolAmerican sleep clinicRuben de franciscoPresentation session

Promontory Therapeutics to Present Research on PT-112 in Prostate Cancer at the 34th EORTC-NCI-AACR Symposium

/PRNewswire/ Promontory Therapeutics Inc., a clinical stage pharmaceutical company advancing small molecule immunotherapies in oncology, today announced.

United statesBaja californiaComunidad autonoma de catalunaRuth soler agestaMark corbaeStephanie carringtonTaylorb youngPromontory therapeutics incNational cancer instituteUniversity of zaragozaPrnewswire promontory therapeutics incAmerican association for cancer researchMerck kgaMerck kgaaVirtual congressStrategic development

Aeglea BioTherapeutics Announces Presentations at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium 2022

AUSTIN, Texas, Aug. 29, 2022 /PRNewswire/ Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE), a clinical-stage biotechnology company developing a new .

United statesEmory university school of medicineRossana sanchez russoAeglea biotherapeuticsGeorgiaabout aeglea biotherapeuticsDanielle starinChildren national hospitalAeglea biotherapeutics incInborn errorsAnnual symposiumHomocystinuria presentationsPresentation timePresentation sessionNational hospitalEmory university schoolGeorgiaabout aeglea

Aeglea BioTherapeutics Announces Presentations at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium 2022

/PRNewswire/ Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics to.

United statesEmory university school of medicineRossana sanchez russoDanielle starinChildren national hospitalAeglea biotherapeutics incInborn errorsAnnual symposiumPresentation timePresentation sessionNational hospitalEmory university schoolAeglea biotherapeutics

vimarsana © 2020. All Rights Reserved.